Sort
15,440 grants matching “organoids”
Regulation of the intestinal stem cell compartment after hematopoietic transplantation
$558,680Alan M Hanash · Sloan-Kettering Inst Can Research · R01 · FY2015 · HL
Regulation of the intestinal stem cell compartment after hematopoietic transplantation
$558,680Alan M Hanash · Sloan-Kettering Inst Can Research · R01 · FY2018 · HL
Regulation of the intestinal stem cell compartment after hematopoietic transplantation
$558,680Alan M Hanash · Sloan-Kettering Inst Can Research · R01 · FY2017 · HL
Regulation of the intestinal stem cell compartment after hematopoietic transplantation
$558,680Alan M Hanash · Sloan-Kettering Inst Can Research · R01 · FY2016 · HL
Translational Epigenetics with XIST: Silencing Trisomy in Human Organoid and Mouse Models of Down Syndrome
$558,510Jeanne Bentley Lawrence · Univ Of Massachusetts Med Sch Worcester · R01 · FY2022 · HD
HER2-mediated delivery of cytotoxic agents in solid tumors
$558,399Sarat Chandarlapaty · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Roles of circHIPK3 and HuR in aging gut barrier function
$558,222Lan Xiao · University Of Maryland Baltimore · R01 · FY2024 · AG
Regulation of Endometriotic Lesion Development by NOTCH1
$558,214Asgerally T. Fazleabas · Michigan State University · R01 · FY2022 · HD
Regulation of Endometriotic Lesion Development by NOTCH1
$558,214Asgerally T. Fazleabas · Michigan State University · R01 · FY2023 · HD
Control of lung alveolar regeneration by Dot1L/H3K79 methylation
$558,156Edward E Morrisey · University Of Pennsylvania · R01 · FY2024 · HL
Pharmacogenomic and circulating tumor cell approach to individualized treatment of pancreatic cancer
$558,143Kenneth H. Yu · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA
Pharmacogenomic and circulating tumor cell approach to individualized treatment of pancreatic cancer
$558,143Kenneth H. Yu · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA
The role of RAMS11 in colorectal cancer progression and treatment resistance
$558,058Christopher A Maher · Washington University · R01 · FY2022 · CA
Centrosome instability as a mechanism to promote localized prostate cancer
$557,995Gregory Charles Rogers · University Of Arizona · R01 · FY2019 · CA
Centrosome instability as a mechanism to promote localized prostate cancer
$557,995Gregory Charles Rogers · University Of Arizona · R01 · FY2020 · CA
Centrosome instability as a mechanism to promote localized prostate cancer
$557,995Gregory Charles Rogers · University Of Arizona · R01 · FY2021 · CA
Defining immunological mechanisms of serovar cross-reactivity to develop broad spectrum protective vaccines for typhoidal and non-typhoidal Salmonella infections in humans
$557,858Marcelo B. Sztein · University Of Maryland Baltimore · U19 · FY2019 · AI
Developing translationally-relevant genetically engineered mouse models of lung adenocarcinoma for investigations in cancer immunology
$557,766Nikhil Joshi · Yale University · R01 · FY2020 · CA
Developing translationally-relevant genetically engineered mouse models of lung adenocarcinoma for investigations in cancer immunology
$557,766Nikhil Joshi · Yale University · R01 · FY2021 · CA
Developing translationally-relevant genetically engineered mouse models of lung adenocarcinoma for investigations in cancer immunology
$557,766Nikhil Joshi · Yale University · R01 · FY2022 · CA
Center for Circadian Rhythms and Alcohol-Induced Tissue Damage
$557,764Ali Keshavarzian · Rush University Medical Center · R24 · FY2025 · AA
Protective role of Neuregulin-1 against cerebral malaria-induced neuronal injury and behavioral sequelae
$557,752Jonathan K. Stiles · Morehouse School Of Medicine · R01 · FY2022 · NS
(PQB6)An Integrative Computational and Bioengineered Tissue Model of Metastasis
$557,736David B Agus · University Of Southern California · R01 · FY2014 · CA
Molecular Characterization of Joubert Syndrome
$557,723Joseph G Gleeson · Rockefeller University · R01 · FY2016 · NS
Coordinated regeneration of lung epithelial and endothelial compartments
$557,634Andrew Vaughan · University Of Pennsylvania · R01 · FY2023 · HL